Tissue banks operate under conditions comparable neither to cell culture nor to a conventional biobank. They store structured, multi-layered grafts — corneas, bone, tendons, skin, heart valves and vessels — that must remain not merely viable but functional.
A cryopreserved heart valve has to be mechanically load-bearing after thawing. A bone graft has to retain its structure. That is a different requirement from a cell suspension, where a statistical loss of viability is tolerable.
In a cell suspension, every cell sits individually in medium and is evenly surrounded by cryoprotectant. In a block of tissue, none of that holds:
The conclusion follows: for tissue, controlled programmed freezing is not one option among several. It is the precondition.
Tissue preservation requires a precisely executed and documented temperature profile. The BIOFREEZE® BV45 and BIOFREEZE® SMARTLINE from Consarctic® deliver exactly that:
For tissue, the contamination question is sharper than for almost any other sample type. Grafts go directly into a patient; cross-contamination cannot be corrected by downstream processing.
Because liquid nitrogen is not a sterile medium and can penetrate imperfectly sealed packaging, vapor phase storage above the LN₂ level is effectively the standard in tissue banking.
The challenge is the vertical temperature gradient: every released position must stay permanently below –130 °C. Consarctic® cryogenic tanks address this through the eccentric tank opening, which reduces the evaporation surface, lowers vapor-phase temperature, flattens the gradient and simultaneously cuts LN₂ consumption by up to 30 %.
For long-term storage, the BSD+ series (stainless steel, scalable to 100,000 cryovials) and the BSF+ series (up to 1,700 × 500 ml bags) are available — the latter particularly suited to large-volume and sheet-form grafts such as bagged skin preparations. Custom-engineered racks and cassettes accommodate special formats that fit no standard grid: bone segments, tendons, valve preparations.
Tissue donations undergo infectious disease testing whose results are not fully available until after storage begins. Until release, the preparation must be stored physically separately and identified unambiguously as not released.
In practice, separation at tank level works better than at rack level: dedicated tanks for quarantine and for released inventory. This prevents retrieval mix-ups, makes release status visible at any time without consulting the database, and simplifies every audit.
The European framework for tissues and cells — Directive 2004/23/EC and its national implementations — requires gap-free traceability from donor to recipient and back, across decades.
For cryogenic infrastructure that means, concretely:
The Consarctic® Monitoring System provides the continuous surveillance with remote access and alarm forwarding. IQ/OQ qualification including temperature mapping is performed by certified technicians with GMP-compliant documentation to EN ISO 13485:2016 and ISO 9001:2015. The 24/7 emergency service is available 365 days a year.
Tissue bank and treating clinic are rarely in the same place. The ASR+ dry shipper series transports cryopreserved grafts with no free liquid nitrogen: IATA-compliant for air transport, orientation-independent even if tipped, and passive, with no pump or power supply. The optional integrated data logger documents the temperature profile without gaps and closes the chain of custody through to application.
Cryopreserved holdings typically include heart valves, blood vessels, bone and bone segments, tendons and ligaments, skin and amniotic membrane. Corneas are, depending on the method, also stored at culture temperature or hypothermically; where cryopreserved long-term storage is used, the same requirements apply as for other tissues.
Because cryoprotectants must diffuse into the tissue, because a tissue block cools faster at the surface than at the core, and because ice crystals destroy not only cells but collagen structures and cell junctions. In addition, many grafts contain several cell types with different protocol optima.
Because grafts go directly into a patient and cross-contamination cannot be corrected afterwards. Liquid nitrogen is not sterile and can penetrate imperfectly sealed packaging. Vapor phase storage above the LN₂ level designs that transmission route out entirely.
In the EU, Directive 2004/23/EC provides the framework, transposed into national law in each member state. The central obligations are gap-free traceability from donor to recipient, documented storage conditions, and qualified processes.
In validated dry shippers. The Consarctic® ASR+ series carries no free liquid nitrogen, making it IATA-compliant and orientation-independent, and documents the temperature profile through to the transplant centre via an optional integrated data logger.
For a cell suspension, 85 % viability is a result. For a graft, the question is binary: functional or not. Only an infrastructure in which freezing protocol, storage temperature, quarantine management, documentation and transport were designed together can carry that requirement.
Building a tissue bank, or expanding an existing one? Consarctic GmbH plans, supplies, qualifies and supports complete cryogenic infrastructure — from controlled rate freezers through tanks and monitoring to validated transport. Talk to our engineers.